drugset
drugset / Trial / NCT00796614

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

NCT00796614 ↗

Phase 2/3 Completed 231 enrolled Boehringer Ingelheim
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Aim of this study is to evaluate the efficacy and safety of a range of doses of tamsulosin hydrochloride as treatment in children with an elevated detrusor leak point pressure associated with a known neurological deficit

Timeline

Start
2008-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamsulosin Other / unclassified 0.001 mg/kg Oral
Subject Tamsulosin Other / unclassified 0.002 mg/kg Oral
Subject Tamsulosin Other / unclassified 0.004 mg/kg Oral
Subject Tamsulosin Other / unclassified 0.008 mg/kg Oral

Indications

urinary bladder disorder